Biogen Inc. agreed to pay $900 million to settle allegations that it paid kickbacks to doctors to induce them to prescribe the company’s drugs, the Justice Department said Monday.
From 2009 to March 2014, Biogen allegedly used speaking and consulting fees and other remuneration to persuade doctors to prescribe the company’s multiple sclerosis drugs such as Avonex and Tecfidera, which resulted in fraudulent payments by Medicare and Medicaid for the drugs, according to a federal whistleblower lawsuit filed in 2012 by former Biogen employee Michael Bawduniak. The suit was unsealed in 2015